Hawiger cofounded in 2014 to sponsor clinical trials of the drug.
The short answer
This parenteral preparation is indicated only for diluting or dissolving drugs for intravenous, intramuscular or subcutaneous injection, according to instructions of the manufacturer of the drug to be administered
By reducing NNMT activity, the 5-Amino-1MQ peptide may enhance cellular energy expenditure, promote fat loss, and improve metabolic efficiency (1)
To find out if your insurance will cover the injections, review your policy details regarding injectable medications and preventive care, consult your healthcare provider to determine if they can document a medical necessity (which can increase the likelihood of coverage), and contact your insurance company directly to inquire about specifics like co-pays, deductibles, and any prior authorization requirements
Reliable customer support